Naziv nasal, 22.5mkg / dose, 10ml, # 1

Dosage form

Dosed nasal spray

Structure

Oxymetazoline 0.500mg

Auxiliary substances: lemon to-you monohydrate, sodium citrate dihydrate, glycerol / 85% /, water

pharmachologic effect

Adrenomimetic agent for topical use.

Has a vasoconstrictor effect.

With intranasal administration, the swelling of the mucous membrane of the upper respiratory tract decreases.

When instilled into the conjunctival sac, it reduces the swelling of the conjunctiva.

Pharmacokinetics

The effect is manifested 15 minutes after application and lasts for 6-8 hours.

Side effects

From the respiratory system: transient dryness and burning of the nasal mucosa, dry mouth and throat, sneezing are possible

with prolonged use, the appearance of reactive hyperemia of the mucous membrane, atrophy of the mucous membrane is possible.

On the part of the cardiovascular system: palpitations

rarely - arterial hypertension.

From the side of the central nervous system: increased excitability, dizziness, headache, sleep disturbances

with prolonged use - tachyphylaxis.

From the digestive system: nausea.

From the side of the organ of vision: with conjunctival administration, mydriasis, paresis of accommodation, irritation of the conjunctiva and surrounding tissues, retraction of the eyelids are possible

Selling features

Available without a prescription

Indications Difficulty in nasal breathing with colds, sinus inflammation, eustachitis, hay fever, allergic rhinitis, congestion and edema of the conjunctiva.

Contraindications

Inflammation of the nasal mucosa without secretion, chronic heart failure, hyperthyroidism, diabetes mellitus, pregnancy, children under 6 years of age (for eye drops), hypersensitivity to oxymetazoline, atrophic rhinitis, lactation period, arrhythmias, severe atherosclerosis, arterial hypertension, chronic renal failure , angle-closure glaucoma.

Drug interactions

With the simultaneous appointment of MAO inhibitors and tricyclic antidepressants, an increase in blood pressure is possible.

Oxymetazoline slows down the absorption of local anesthetic drugs, lengthens their effect.

The co-administration of other vasoconstrictor drugs increases the risk of side effects.

Dosage

Apply topically.

Name ENG

NASIVIN SENSITIVE

Clinical and pharmacological group

A vasoconstrictor drug for local use in ENT practice

ATX code

Oxymetazoline

Dosage

22.5mcg / dose x 10ml

Structure

Oxymetazoline 0.500mg

Auxiliary substances: lemon to-you monohydrate, sodium citrate dihydrate, glycerol / 85% /, water.

Indications

Colds or viral infections of the upper respiratory tract, accompanied by a runny nose, sinusitis, eustachitis, otitis media, rhinitis of any etiology

- to eliminate edema before diagnostic manipulations in the nasal passages.

INN / Active ingredient

Oxymetazoline

Contraindications

Atrophic rhinitis angle-closure glaucoma hypersensitivity to the components of the drug surgical interventions on the dura mater (in history). For the drug Nazivin® Sensitiv nasal spray dosed 11.25 mcg / dose - children under 1 year of age. With caution: With increased intraocular pressure, chronic heart failure, arterial hypertension, angina pectoris arrhythmias chronic renal failure in patients with prostatic hyperplasia with clinical symptoms (urinary retention) severe atherosclerosis with hyperthyroidism diabetes mellitus pheochromocytoma tachycardia therapy with monoamine oxidase (MAO) inhibitors and tricyclic antidepressants, as well as other drugs that increase blood pressure porphyrias. Pregnancy and lactation:When used during pregnancy or breastfeeding, the recommended dose should not be exceeded. The drug can only be used if the potential benefit to the mother outweighs the potential risk to the fetus and child.

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 3 years

Specifications

Category

Runny nose

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Spain

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

1 year

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Takeda

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA05 Oxymetazoline

Dosage form

Dosed nasal spray

The target audience

Adult

Dosage (volume) of the substance in the preparation

oxymetazoline hydrochloride 22.5μg

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

One 45 μl spray contains 11.25 μg oxymetazoline hydrochloride.

Children aged 1 to 6 years - 1 injection of Nazivin Sensitiv nasal spray dosed into each nostril 2-3 times a day.

The drug is used for 5–7 days.

The drug can be re-prescribed only after a few days.

Information on technical characteristics, delivery set, country of manufacture